Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neoplasm
100%
Radiation Therapy
96%
Overall Survival
81%
Neck Radiotherapy
72%
Head Radiotherapy
72%
Contouring
72%
Radiation Therapy
72%
Lung Cancer
69%
Non Small Cell Lung Cancer
36%
Coronary Artery
36%
Isotopes of Calcium
36%
Small Cell Lung Cancer
36%
Diseases
36%
Dose Calculation
36%
Dual Energy Computed Tomography
36%
Cell Cycle M Phase
36%
Re-Irradiation
36%
Image Registration
36%
Malignant Neoplasm
33%
Computer Assisted Tomography
30%
Anatomy
24%
Oropharynx
24%
DNA Template
24%
Squamous Cell Carcinoma
24%
Head and Neck Cancer
24%
Cancer Radiotherapy
24%
Lung
23%
Cross-Validation
21%
Hazard Ratio
21%
Principal Component Analysis
18%
Bootstrapping
15%
Patient Characteristics
15%
Proportional Hazards Model
15%
Isoniazid
9%
Artery
9%
Radiation Therapy Planning
9%
Cancer Registry
9%
Primary Tumor
9%
Esophagus
9%
Lymph Node
9%
Distance Measurement
7%
Anatomical Concepts
7%
Drug Megadose
7%
Left Ventricle
6%
Non-Small Cell Lung Cancer
6%
Survival Prediction
6%
Body Mass Index
6%
Right Atrium
6%
Keyphrases
Contouring Guidelines
72%
Gross Tumor Volume
72%
Clinical Target Volume Margins
72%
Substructure Development
36%
Stereotactic Body Radiotherapy
36%
Head-and-neck Radiotherapy
36%
Ultra-central Lung Tumor
36%
Clinical Target Volume
36%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
36%
Geometric Margin
36%
Overall Survival
36%
Definitive Radiotherapy
36%
Radiotherapy Plan
36%
Coronary Artery Calcium Score
36%
Dose-escalated Radiotherapy
36%
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
36%
Dual-energy Computed Tomography
36%
Multienergy Computed Tomography
36%
Stereotactic Ablative Radiotherapy
36%
EQD2
36%
Image Dose
36%
Automatic Delineation
18%
Cardiac Comorbidities
18%
Interobserver Reliability
18%
Surface Distance
18%
Intermediate Dose
18%
Cancer Radiotherapy
18%
Uniform Treatment
18%
Irradiated Volume
18%
Dummy Run
18%
Volume Difference
18%
Non-small Cell Lung Cancer Patients
18%
Heart Irradiation
14%
Dose Prediction
12%
Hybrid Segmentation
12%
Overdosage
10%
Bootstrap
9%
Prognostic Information
9%
Tumor Volume
9%
Cox Model
9%
Performance Status
9%
Calcium Score
9%
Multivariable
9%
Non-cancer
9%
Head-and-neck Cancer
9%
Clinical Target Volume Delineation
9%
Univariable Analysis
9%
Lung Cancer Registry
9%
Large Volume
9%
Competing Risk Analysis
9%